doi:10.3969/j.issn.1004-583X.2026.03.013

Abstract

CLC Number:

R743.34

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.03.013

https://www.lchc.cn/EN/Y2026/V41/I3/269

References 43

[1]	Wu S, Wu B, Liu M, et al. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405. doi:10.1016/S1474-4422(18)30500-3. pmid: 30878104
[2]	Kim JY, Bae HJ. Spontaneous intracerebral hemorrhage: Management[J]. J Stroke, 2017, 19(1):28-39. doi:10.5853/jos.2016.01935. pmid: 28178413
[3]	Muhammad S, Chaudhry SR, Kahlert UD, et al. Brain immune interactions-novel emerging options to treat acute ischemic brain injury[J]. Cells, 2021, 10(9):2429. doi:10.3390/cells10092429.
[4]	Babu R, Bagley JH, Di C, et al. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention[J]. Neurosurg Focus, 2012, 32(4):E8. doi:10.3171/2012.1.FOCUS11366.
[5]	Guo YJ, Pan WW, Liu SB, et al. ERK/MAPK signalling pathway and tumorigenesis[J]. Exp Ther Med, 2020, 9(3):1997-2007. doi:10.3892/etm.2020.8454.
[6]	He Y, Meng X. MAPK signaling: Emerging roles in lateral root formation[J]. Trends Plant Sci, 2020, 25(2):126-129. doi:10.1016/j.tplants.2019.11.006. pmid: 31848035
[7]	Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: An update[J]. Arch Toxicol, 2015, 89(6):867-882. doi:10.1007/s00204-015-1472-2. pmid: 25690731
[8]	Plotnikov A, Zehorai E, Procaccia S, et al. The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation[J]. Biochim Biophys Acta, 2011, 1813(9):1619-1633. doi:10.1016/j.bbamcr.2010.12.012. pmid: 21167873
[9]	乔羽, 项楠, 周忠光, 等. 桦褐孔菌醇提物对胃癌模型裸鼠和BGC-823胃癌细胞Ras/MAPK信号通路的影响[J]. 中医药信息, 2023, 40(11):7-12.doi:10.19656/j.cnki.1002-2406.20231102.
[10]	Moon H, Ro SW. MAPK/ERK signaling pathway in hepatocellular carcinoma[J]. Cancers (Basel), 2021, 13(12):3026. doi:10.3390/cancers13123026.
[11]	Zhang H, Tang W, Wang S, et al. Tetramethylpyrazine inhibits platelet adhesion and inflammatory response in vascular endothelial cells by inhibiting P38 MAPK and NF-κB signaling pathways[J]. Inflammation, 2020, 43(1):286-297. doi:10.1007/s10753-019-01119-6. pmid: 31720990
[12]	孔莹, 段洪超, 刘洋, 等. 头穴透刺对JNK通路抑制后脑出血大鼠脑组织p-STAT3影响的研究[J]. 中国中医急症, 2017, 26(11):1895-1898.
[13]	Liu Y, Han J, Zhou Z, et al. Paeoniflorin protects pancreatic β cells from STZ-induced damage through inhibition of the p38 MAPK and JNK signaling pathways[J]. Eur J Pharmacol, 2019, 853:18-24. doi:10.1016/j.ejphar.2019.03.025. pmid: 30880178
[14]	孔德敏, 邹伟. 脑出血后小胶质细胞极化及其相关炎症信号通路对继发性脑损伤的影响[J]. 中国卒中杂志, 2023, 18(11):1315-1323.
[15]	薛战尤, 王安海, 赵元, 等. 香芹酚通过MAPK/ERK信号通路对缺血再灌注后脑损伤大鼠的保护作用[J]. 临床和实验医学杂志, 2018, 17(23):2473-2476.
[16]	李小娟, 张智博. MEK/ERK信号通路与脑缺血再灌注损伤[J]. 现代生物医学进展, 2013, 13(9):1793-1796.
[17]	刘敏, 华茜, 于雪, 等. 新清开灵干预脑出血后急性期ERK1/2、c-fos、c-jun的实验研究[J]. 辽宁中医杂志, 2014, 41(3):577-580.
[18]	Wang ZQ, Wu DC, Huang FP, et al. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia[J]. Brain Res, 2004, 996(1):55-66. doi:10.1016/j.brainres.2003.09.074.
[19]	Chu H, Tang Y, Dong Q. Protection of vascular endothelial growth factor to brain edema following intracerebral hemorrhage and its involved mechanisms: Effect of aquaporin-4[J]. PLoS One, 2013, 8(6):e66051. doi:10.1371/journal.pone.0066051.
[20]	朝博, 任君浩, 苏优勒. 塞来昔布通过MAPK/ERK信号通路抑制炎症反应改善急性脑出血大鼠神经功能的机制研究[J]. 中国药师, 2023, 26(11):181-188.
[21]	Tang J, Yan B, Tang Y, et al. Baicalein ameliorates oxidative stress and brain injury after intracerebral hemorrhage by activating the Nrf2/ARE pathway via miR-106a-5p/PHLPP2 axis[J]. Int J Neurosci, 2023, 133(12):1380-1393. doi:10.1080/00207454.2022.2080676.
[22]	Wang F, Li WL, Shen LJ, et al. Crocin alleviates intracerebral hemorrhage-induced neuronal ferroptosis by facilitating Nrf2 nuclear translocation[J]. Neurotox Res, 2022, 40(2):596-604. doi:10.1007/s12640-022-00500-y. pmid: 35380368
[23]	赵莹, 赵晶. 酒石酸布托啡诺基于JNK/NF-κB信号通路对大鼠脑缺血再灌注损伤的改善作用[J]. 河北医药, 2023, 45(3):325-329.
[24]	Linton MF, Babaev VR, Huang J, et al. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis[J]. Circ J, 2016, 80(11):2259-2268. doi:10.1253/circj.CJ-16-0924. pmid: 27725526
[25]	Shvedova M, Anfinogenova Y, Atochina-Vasserman EN, et al. c-Jun N-Terminal Kinases (JNKs) in myocardial and cerebral ischemia/reperfusion injury[J]. Front Pharmacol, 2018, 9:715. doi:10.3389/fphar.2018.00715. pmid: 30026697
[26]	孟文文, 刘永海. 阿加曲班改善脑出血大鼠神经功能的可能机制[J]. 临床医药文献电子杂志, 2019, 6(41):167-169.
[27]	Zhou YY, Li Y, Jiang WQ, et al. MAPK/JNK signalling: A potential autophagy regulation pathway[J]. Biosci Rep, 2015, 35(3):e00199. doi:10.1042/BSR20140141.
[28]	边寰, 徐浩翔, 杨悦凡, 等. MAPK信号通路在创伤性脑损伤中的作用[J]. 中华神经外科疾病研究杂志, 2013, 12(3):210-213.
[29]	王星智, 祖洁, 昝坤, 等. JNK抑制肽XG-102在大鼠脑出血中的保护作用[J]. 徐州医学院学报, 2014, 34(6):384-387.
[30]	董西朝, 王林林, 张亮, 等. 烟酰胺经调控p38MAPK信号通路对高血压脑出血大鼠的脑保护作用机制分析[J]. 现代生物医学进展, 2023, 23(18):3431-3435+3444.
[31]	周官恩, 饶明俐, 刘宗超. 实验性大鼠尾壳核脑出血后p38MAPK、ICAM-1的动态表达[J]. 中风与神经疾病杂志, 2006, (3):273-276.
[32]	李泽飞, 赵宾宾, 石和元, 等. 基于p38 MAPK信号通路探讨生慧颗粒对AD模型大鼠EC与CA1区影响及作用机制[J]. 世界科学技术-中医药现代化, 2024, 26(1):157-166.
[33]	郑人源, 张琴, 卓强, 等. 阻断p38MAPK信号通路对大鼠肝星状细胞活性及c-myc蛋白表达的影响[J]. 重庆医学, 2014, 43(25):3307-3310.
[34]	Pez F, Dayan F, Durivault J, et al. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth[J]. Cancer Res, 2011, 71(5):1647-1657. doi:10.1158/0008-5472.CAN-10-1516. pmid: 21239473
[35]	Park SH, Seong MA, Lee HY. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells[J]. Oncotarget, 2016, 7(7):8184-8199. doi:10.18632/oncotarget.6945.
[36]	于华, 曲莉. 基于p38MAPK/SERCA2α通路观察羟基红花黄色素A对大鼠心肌缺血/再灌注损伤的保护作用[J]. 中国免疫学杂志, 2023, 39(7):1395-1401+1408.
[37]	王晓天, 刘晓梅, 尤红娟, 等. p38MAPK介导的Fas/FasL凋亡通路在缺血性脑损伤中的作用研究[J]. 中国医药指南, 2014, 12(31):1-2.
[38]	Josephs SF, Ichim TE, Prince SM, et al. Unleashing endogenous TNF-alpha as a cancer immunotherapeutic[J]. J Transl Med, 2018, 16(1):242. doi:10.1186/s12967-018-1611-7. pmid: 30170620
[39]	刘学文, 朱锦莉, 田步先, 等. p38丝裂原活化蛋白激酶信号通路特异性阻滞药对癫痫模型大鼠神经细胞的保护作用研究[J]. 中国药房, 2012, 23(25):2321-2323.
[40]	Molz S, Decker H, Dal-Cim T, et al. Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38 MAPK signaling[J]. Neurochem Res, 2008, 33(1):27-36. doi:10.1007/s11064-007-9402-1. pmid: 17616814
[41]	Chaparro-Huerta V, Flores-Soto ME, Gudiño-Cabrera G, et al. Role of p38 MAPK and pro-inflammatory cytokines expression in glutamate-induced neuronal death of neonatal rats[J]. Int J Dev Neurosci, 2008, 26(5):487-495. doi:10.1016/j.ijdevneu.2008.02.008. pmid: 18396383
[42]	金曼, 吕佩源. P38蛋白激酶在神经细胞凋亡及长时程抑制过程中的作用[J]. 国际神经病学神经外科学杂志, 2010, 37(5):473-476.
[43]	Cai Y, Cho GS, Ju C, et al. Activated microglia are less vulnerable to hemin toxicity due to nitric oxide-dependent inhibition of JNK and p38 MAPK activation[J]. J Immunol, 2011, 187(3):1314-1321. doi:10.4049/jimmunol.1002925. pmid: 21709153

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 43

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xu Huifeng, Jin Yanyong, Gou Ruolan, Hu Mingzhe. Risk factors for hydrocephalus in children with cerebral hemorrhage and its prediction model [J]. Clinical Focus, 2025, 40(4): 325-328.
[2]	Liu Jinteng, Liu Xingyu, Huang Lumei, Pan Hailong. The risk prediction models for pneumonia in patients with intracerebral hemorrhage: A systematic review [J]. Clinical Focus, 2025, 40(1): 5-13.
[3]	. [J]. Clinical Focus, 2021, 36(6): 562-565.
[4]	Wu Liang, Liu Ming. Relations between serum immunoglobulin, level of complement C3 or complement C4 and prognosis of hypertensive intracerebral hemorrhage patients [J]. Clinical Focus, 2021, 36(2): 107-111.
[5]	WANG Peng-fei;DONG Li-quan;XIONG Xiao-yi;YANG Qing-wu. Upper extremity remote ischemic preconditioning relieves cerebral injury of patients with undergoing severe carotid stenosis stent implantation [J]. Clinical Focus, 2014, 29(1): 21-24.
[6]	HAN Zhuang;TIAN Yun-xia;WANG Xiu-zhong;GUO Jian-hong;LI Shi-ling;ZHANG Wei;ZHAO Jian;ZHANG Xu-jing. Diagnosis value of susceptibility weighted imaging in cerebral microbleeds [J]. CLINICAL FOCUS, 2013, 28(10): 1104-1106.
[7]	. [J]. CLINICAL FOCUS, 2013, 28(10): 1173-1173.
[8]	. [J]. CLINICAL FOCUS, 2013, 28(9): 1031-1032.
[9]	. [J]. CLINICAL FOCUS, 2013, 28(9): 1063-1065.
[10]	. [J]. CLINICAL FOCUS, 2013, 28(8): 925-926.
[11]	. [J]. CLINICAL FOCUS, 2013, 28(7): 777-779.
[12]	. [J]. CLINICAL FOCUS, 2013, 28(7): 794-796.
[13]	. [J]. CLINICAL FOCUS, 2013, 28(6): 677-679.
[14]	. [J]. Clinical Focus, 2013, 28(5): 561-562.
[15]	LIU Qiu-ting;TU E-wen;LI Jun-feng;WU Jun. Effects of atorvastatin on expression of matrix metalloproteinase-9 and brain edema in brain tissue of rats with experimental cerebral hemorrhage [J]. CLINICAL FOCUS, 2013, 28(3): 298-301.